GSK seeks FDA approval for investigational HIV treatment
December 05, 2019 at 07:34 AM EST
GlaxoSmithKline Plc said on Thursday its HIV unit has submitted a new drug application to the U.S. Food and Drug Administration seeking approval for fostemsavir, an experimental treatment for HIV in adults.